Innovation in BCMA CAR-T therapy: Building beyond the Model T

Autologous chimeric antigen receptor T-cell (CAR-T) therapies targeting B-cell maturation antigen (BCMA) have revolutionized the field of multiple myeloma in the same way that the Ford Model T revolutionized the original CAR world a century ago. However, we are only beginning to understand how to im...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Rahul, Lee, Sarah S., Cowan, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729952/
https://www.ncbi.nlm.nih.gov/pubmed/36505779
http://dx.doi.org/10.3389/fonc.2022.1070353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729952/
https://www.ncbi.nlm.nih.gov/pubmed/36505779
http://dx.doi.org/10.3389/fonc.2022.1070353

Ejemplares similares